Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
AKBA holding history
Akebia Therapeutics, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKBA overviewAll 13F holders of AKBAFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q1 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −2,450,000−100.0% | Sold out | Holders |
| Q3 2025 | 2,450,000 | $6.69M | 0.6% | +500,000+25.6% | Added | Holders |
| Q2 2025 | 1,950,000 | $7.10M | 1.0% | +450,000+30.0% | Added | Holders |
| Q1 2025 | 1,500,000 | $2.88M | 0.5% | +1,500,000 | New | Holders |